Literature DB >> 28776595

Role of intralesional bleomycin sclerotherapy as the sole or adjunct treatment of superficial ocular adnexal lymphatic malformations.

N Bothra1, L Panda1, J Sheth1, D Tripathy1.   

Abstract

ObjectiveTo report the role of intralesional bleomycin as sole or adjunct therapy in the management of superficial ocular adnexal lymphatic malformations.DesignRetrospective study.ParticipantsThree patients/three eyes.MethodsRetrospective chart analysis of patients receiving intralesional bleomycin sclerotherapy as sole or adjunctive treatment for superficial ocular adnexal lymphatic malformations at a single tertiary level eye care institution.ResultsDegree of clinical regression of the lesions (graded by percentage) and resolution of symptoms and signs associated with the lesions.ConclusionsUse of intralesional bleomycin sclerotherapy appears to be an effective sole or adjunct treatment in the management of superficial ocular adnexal lymphatic malformations.

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28776595      PMCID： PMC5770705          DOI： 10.1038/eye.2017.154

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN： 0950-222X            Impact factor:   3.775


  12 in total

1.  Management of orbital lymphangioma using intralesional injection of OK-432.

Authors:  Y Suzuki; A Obana; Y Gohto; T Miki; H Otuka; Y Inoue
Journal:  Br J Ophthalmol       Date:  2000-06       Impact factor: 4.638

2.  Intralesional bleomycin: a potential treatment for refractory orbital lymphangiomas.

Authors:  Caroline Gooding; David Meyer
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2014 May-Jun       Impact factor: 1.746

3.  Percutaneous drainage and ablation as first line therapy for macrocystic and microcystic orbital lymphatic malformations.

Authors:  Robert H Hill; William E Shiels; Jill A Foster; Craig N Czyz; Andrew Stacey; Kelly R Everman; Kenneth V Cahill
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2012 Mar-Apr       Impact factor: 1.746

Review 4.  Vascular malformations of the orbit: classification and the role of imaging in diagnosis and treatment strategies*.

Authors:  Jack Rootman; Manraj K S Heran; Douglas A Graeb
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2014 Mar-Apr       Impact factor: 1.746

Review 5.  Orbital lymphangiomas: a review of management strategies.

Authors:  Konal Saha; Brian Leatherbarrow
Journal:  Curr Opin Ophthalmol       Date:  2012-09       Impact factor: 3.761

6.  Sclerotherapy treatment of orbital lymphatic malformations: a large single-centre experience.

Authors:  Alex M Barnacle; Maria Theodorou; Sarah J Maling; Yassir Abou-Rayyah
Journal:  Br J Ophthalmol       Date:  2015-06-17       Impact factor: 4.638

Review 7.  Complications of intralesional bleomycin in the treatment of orbital lymphatic malformations.

Authors:  Peter W MacIntosh; Michael K Yoon; Aaron Fay
Journal:  Semin Ophthalmol       Date:  2014 Sep-Nov       Impact factor: 1.975

8.  Comparative analysis of intralesional sclerotherapy with sodium tetradecyl sulfate versus bleomycin in the management of low flow craniofacial soft tissue vascular lesions.

Authors:  Hemant Bajpai; Sarika Bajpai
Journal:  J Maxillofac Oral Surg       Date:  2011-12-28

9.  Treatment of orbital vascular malformations with intralesional injection of pingyangmycin.

Authors:  Han Yue; Jiang Qian; Victor M Elner; Jie Guo; Yi-Fei Yuan; Rui Zhang; Qin Ge
Journal:  Br J Ophthalmol       Date:  2013-04-19       Impact factor: 4.638

10.  Pingyangmycin as first-line treatment for low-flow orbital or periorbital venous malformations: evaluation of 33 consecutive patients.

Authors:  Renbing Jia; Shiqiong Xu; Xiaolin Huang; Xin Song; Hui Pan; Leilei Zhang; Fanglin He; Ming Lin; Shengfang Ge; Xianqun Fan
Journal:  JAMA Ophthalmol       Date:  2014-08       Impact factor: 7.389
View more
  4 in total

1.  Long term outcomes of transcutaneous non-image guided bleomycin sclerotherapy in orbital/adnexal lymphatic malformations: a protocol-based management in 69 eyes.

Authors:  Tarjani Vivek Dave; Bejjanki Kavya Madhuri; Srujana Laghmisetty; Devjyoti Tripathy; Swathi Kaliki; Suryasnata Rath; Samir Mohapatra; Akruti Desai; Anasua Ganguly Kapoor
Journal:  Eye (Lond)       Date:  2021-04-20       Impact factor: 3.775

2.  Sinusoidal Microchannel with Descending Curves for Varicose Veins Implantation.

Authors:  Muhammad Javaid Afzal; Muhammad Waseem Ashraf; Shahzadi Tayyaba; M Khalid Hossain; Nitin Afzulpurkar
Journal:  Micromachines (Basel)       Date:  2018-01-31       Impact factor: 2.891

Review 3.  Recent Progress in Lymphangioma.

Authors:  Xiaowei Liu; Cheng Cheng; Kai Chen; Yeming Wu; Zhixiang Wu
Journal:  Front Pediatr       Date:  2021-12-15       Impact factor: 3.418

4.  Bleomycin for orbital and peri-orbital veno-lymphatic malformations - A systematic review.

Authors:  Khunsa Faiz; Stephanos Finitsis; Janice Linton; Jai Jai Shiva Shankar
Journal:  Interv Neuroradiol       Date:  2020-11-11       Impact factor: 1.610
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.